MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 26.02.2026
Certara Langfristiger Schuldenstrom 2011-2026 | CERT
Langfristiger Schuldenstrom Jährlich Certara
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.92 M | 5.31 M | 4.38 M | 4.97 M | 5.04 M | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.31 M | 3.92 M | 4.72 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ACADIA Pharmaceuticals
ACAD
|
9.96 M | $ 22.5 | 1.86 % | $ 3.73 B |  USA |
 |
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M |  Germany |
 |
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | USA |
 |
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | USA |
 |
AlloVir
ALVR
|
316 K | - | 4.14 % | $ 49.1 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
45.5 M | $ 327.16 | 2.39 % | $ 42.9 B | USA |
 |
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | USA |
 |
Amgen
AMGN
|
135 M | $ 349.22 | 2.71 % | $ 188 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
7.93 M | $ 20.4 | -0.87 % | $ 954 M | USA |
 |
Applied Therapeutics
APLT
|
429 K | - | - | $ 8.42 M | USA |
 |
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M |  China |
 |
Aquestive Therapeutics
AQST
|
631 K | $ 4.18 | 1.33 % | $ 447 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
294 K | $ 24.57 | 5.59 % | $ 3.13 B | USA |
 |
AVROBIO
AVRO
|
878 K | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M |  Israel |
 |
AstraZeneca PLC
AZN
|
382 M | - | - | $ 96.9 B |  Britain |
 |
Autolus Therapeutics plc
AUTL
|
4.56 M | $ 1.48 | 8.46 % | $ 394 M | Britain |
 |
BeiGene, Ltd.
BGNE
|
20.7 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
57.6 K | $ 3.85 | 2.41 % | $ 9.26 B |  Australia |
 |
BioNTech SE
BNTX
|
45 M | $ 91.76 | 2.39 % | $ 27.2 B | Germany |
 |
CymaBay Therapeutics
CBAY
|
7 K | - | - | $ 3.45 B | USA |
 |
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | USA |
 |
Aytu BioScience
AYTU
|
137 K | $ 2.71 | 5.51 % | $ 17 M | USA |
 |
Avid Bioservices
CDMO
|
1.35 M | - | - | $ 789 M | USA |
 |
Cidara Therapeutics
CDTX
|
1.38 M | - | - | $ 1.41 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
43 K | $ 3.06 | 0.99 % | $ 6.66 B | Israel |
 |
Cabaletta Bio
CABA
|
3.46 M | $ 3.06 | -0.33 % | $ 307 M | USA |
 |
Cerus Corporation
CERS
|
2.9 M | $ 1.9 | 2.99 % | $ 362 M | USA |
 |
Coherus BioSciences
CHRS
|
1.83 M | $ 1.7 | 1.8 % | $ 199 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
440 K | $ 0.36 | 0.28 % | $ 4.12 M | Israel |
 |
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
181 K | - | -10.17 % | $ 12.2 K | USA |
 |
Concert Pharmaceuticals
CNCE
|
1.16 M | - | - | $ 401 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
437 K | $ 25.57 | 2.3 % | $ 3.13 B | USA |
 |
CTI BioPharma Corp.
CTIC
|
781 K | - | - | $ 1.2 B | USA |
 |
AIkido Pharma
AIKI
|
554 K | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
193 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Cellectar Biosciences
CLRB
|
100 K | $ 2.81 | 2.18 % | $ 7.33 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
3.5 M | - | - | $ 2.18 B | USA |